Sunrest Lifescience Profile
Key Indicators
- Authorised Capital ₹ 14.00 Cr
as on 31-12-2023
- Paid Up Capital ₹ 4.29 Cr
as on 31-12-2023
- Company Age 7 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 3.00 Cr
as on 31-12-2023
- Revenue -8.32%
(FY 2023)
- Profit 162.90%
(FY 2023)
- Ebitda 161.38%
(FY 2023)
- Net Worth 190.88%
(FY 2023)
- Total Assets 28.37%
(FY 2023)
About Sunrest Lifescience
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 14.00 Cr and a paid-up capital of Rs 4.29 Cr.
The company currently has active open charges totaling ₹3.00 Cr.
The Key Managerial Personnel (KMP) at Sunrest Lifescience Limited India are Meha Bhagyesh as CFO and Nishi Shah as Company Secretary. Bhagyesh Parekh, Amitbhai Thakkar, Nikhilkumar Thakkar, and Three other members serve as directors at the Company.
- CIN/LLPIN
U74999GJ2017PLC099606
- Company No.
099606
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
30 Oct 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Sunrest Lifescience?
Executive Team (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Nikhilkumar Thakkar  | Managing Director | 30-Oct-2017 | Current |
| Meha Bhagyesh | CFO | 01-Mar-2023 | Current |
| Nishi Shah | Company Secretary | 01-Mar-2023 | Current |
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Bhagyesh Parekh | Director | 31-Jan-2022 | Current |
| Amitbhai Thakkar | Whole-Time Director | 30-Oct-2017 | Current |
| Bharatkumar Thakkar | Director | 15-Mar-2021 | Current |
| Juhi Sawajani | Director | 01-Mar-2023 | Current |
| Avani Shah | Director | 01-Mar-2023 | Current |
Financial Performance and Corporate Structure Insights of Sunrest Lifescience.
Sunrest Lifescience Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 8.32% decrease. The company also saw a substantial improvement in profitability, with a 162.9% increase in profit. The company's net worth Soared by an impressive increase of 190.88%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sunrest Lifescience?
In 2023, Sunrest Lifescience had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 18 Nov 2023 | ₹3.00 Cr | Open |
How Many Employees Work at Sunrest Lifescience?
Sunrest Lifescience has a workforce of 140 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sunrest Lifescience, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sunrest Lifescience's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
